Monocyte chemoattractant protein-1 inhibitor compounds

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S419000, C546S277400, C548S490000, C548S491000

Reexamination Certificate

active

06953809

ABSTRACT:
The invention concerns the use of a compound of formula (I), in which Z, X, T, A, R1, R2, p and q have any of the meanings defined herein, and their pharmaceutically acceptable salts or in vivo hydrolysable esters, in the treatment of a disease or condition mediated by monocyte chemoattractant protein-1 (MCP-1). Certain of the components of formula (I) are novel and are provided, together with pharmaceutical compositions thereof, as further features of the invention.

REFERENCES:
patent: 3557142 (1971-01-01), Bell
patent: 3776923 (1973-12-01), Remers et al.
patent: 3997557 (1976-12-01), Helsley et al.
patent: 4529724 (1985-07-01), Ho
patent: 4608384 (1986-08-01), Wierzbicki et al.
patent: 4721725 (1988-01-01), Biller et al.
patent: 4751231 (1988-06-01), Halczenko et al.
patent: 4965369 (1990-10-01), Maetzel et al.
patent: 5081145 (1992-01-01), Guindon et al.
patent: 5190968 (1993-03-01), Gillard et al.
patent: 5254563 (1993-10-01), Huth et al.
patent: 5272145 (1993-12-01), Prasit et al.
patent: 5273980 (1993-12-01), Frenette et al.
patent: 5288743 (1994-02-01), Brooks et al.
patent: 5290798 (1994-03-01), Gillard et al.
patent: 5308850 (1994-05-01), Gillard et al.
patent: 5389650 (1995-02-01), Frenette et al.
patent: 5399699 (1995-03-01), Kolasa et al.
patent: 5482960 (1996-01-01), Berryman et al.
patent: 5684032 (1997-11-01), Elliott et al.
patent: 5852046 (1998-12-01), Lang et al.
patent: 5955492 (1999-09-01), Thompson et al.
patent: 6184235 (2001-02-01), Connor et al.
patent: 6288103 (2001-09-01), Faull et al.
patent: 6291507 (2001-09-01), Faull et al.
patent: 6441004 (2002-08-01), Faull et al.
patent: 6479527 (2002-11-01), Barker et al.
patent: 298 913 (1992-03-01), None
patent: 0 077 209 (1983-04-01), None
patent: 0 114 014 (1984-07-01), None
patent: 0 186 367 (1986-07-01), None
patent: 0 189 690 (1986-08-01), None
patent: 0 419 049 (1991-03-01), None
patent: 0 480 659 (1992-04-01), None
patent: 0 535 923 (1993-04-01), None
patent: 0 535 924 (1993-04-01), None
patent: 0 535 925 (1993-04-01), None
patent: 0 535 926 (1993-04-01), None
patent: 0 639 573 (1995-02-01), None
patent: 0 822 185 (1998-02-01), None
patent: 0 275 667 (1998-07-01), None
patent: 2 565 981 (1985-12-01), None
patent: WO 86/00896 (1986-02-01), None
patent: WO 93/12780 (1993-07-01), None
patent: WO 93/16069 (1993-08-01), None
patent: WO 93/20078 (1993-10-01), None
patent: WO 93/25546 (1993-12-01), None
patent: WO 94/14434 (1994-07-01), None
patent: WO 96/03377 (1996-02-01), None
patent: WO 96/18393 (1996-06-01), None
patent: WO 96/31492 (1996-10-01), None
patent: WO 96/33171 (1996-10-01), None
patent: WO 96/37467 (1996-11-01), None
patent: WO 96/37469 (1996-11-01), None
patent: WO 97/12613 (1997-04-01), None
patent: WO 97/12615 (1997-04-01), None
patent: WO 97/30704 (1997-08-01), None
patent: WO 97/35572 (1997-10-01), None
patent: WO 98/06703 (1998-02-01), None
patent: WO 99/33800 (1999-07-01), None
patent: 00/46195 (2000-08-01), None
patent: 00/46196 (2000-08-01), None
patent: 00/46197 (2000-08-01), None
patent: 00/46198 (2000-08-01), None
patent: 00/46199 (2000-08-01), None
patent: 01/51466 (2001-07-01), None
patent: 01/51467 (2001-07-01), None
Bobo{hacek over (s)}ik et al., “Sythesis of N-Phenylsulfonyl Protected Furo[3,2-b]pyrroles”, Collect. Czech. Chem. Commun., vol. 59, 1994, pp. 499-205.
Korobchenko et al., Database Chemabs, Chemical Abstracts Service, Columbus, Ohio, US, AN: 119:62465, XP002105556, see abstract & “Sythesis and antiviral activity of pyrrolecarboxylic acids and their derivatives” KHIM.-FARM.ZH., vol. 26, No. 11-12, 1992, pp. 57-59, see the whole document.
Yokoyama et al.: “Palladium-catalyzed cross-coupling reaction: direct allylation of aryl bromides with allyl acetate” Tetrahedron Letters., vol. 26, No. 52—1985 pp. 6457-6460, XP002081581 Oxford GB * p. 6458-6459: compound 7 *.
Berman et al., “Localization of Monocyte Chemoattractant Peptide-1 . . . Autoimmune Encephalomyelitis and Trauma in the Rat”, Journal of Immunology, 1996, vol. 156, pp. 3017-3023; XP002105551 cited in the application, see the whole document.
Chemical Abstracts, vol. 123, No. 14, Oct. 2, 1995 Columbus, Ohio, US; abstract No. 179521d, Kataoka, Kenichiro et al.: “Homopiperazines as cell migration inhibitors.” Xp002081582 see abstract & JP 95 145060 A (Teijin Ltd).
Dandárová et al., “Reference Data”, Magnetic Resonance in Chemistry, vol. 28, 1990, pp. 830-831.
Database Chemabs, Chemical Abstracts Service, Columbus, Ohio, US, STN, accession No. 125:142551, XP002094570, see abstract. RN 179526-39-7.
Deleuran et al., “Localization of monocyte chemotactic and activating factor (MCAF/MCP-1) in psoriasis”, Journal of Dermatological Science, 1996, vol. 13(3), pp. 228-236; XP002105554 cited in the application, see the whole doucment.
Derwent Abstract for JP 63284177 including Chemical Abstract Registry Records for specific compounds indexed.
Derwent and Chemical Abstracts for International Patent Application, Publication No. WO 92/04343.
Derwent World Patents Index record, JAPIO record and Chemical Abstract for Molecules (1997), 2(4), 69-79, including Chemical Abstract Registry records for specific compounds indexed.
Grimm et al., “Enhanced expression and production of monocyte chemoattractant protein-1 in inflammatory bowel disease mucosa”, Journal of Leukocyte Biology, 1996, vol. 59(6) pp, 804-812; XP002105555 cited in the application, see the whole document.
Harrison et al.; “Cyclopenta[b]indoles, Part 2.1Model studies towards tremorgenic mycotoxins”; Journal of Chemical Society; 1995, pp. 1131-1136; XP 002105550 cited in the application, see p. 1132, Scheme 3, compound 9.
Hartman et al., “The Synthesis of 5-alkylaminomethylthieno[2,3-b]pyrrole-5-sulfonamides”, Heterocycles, vol. 29, 1989, pp. 1943-1949.
Japanese Abstract N-Phenylsulfonylindole derivatives, JP 04273857 A2.
Jones et al., “Potential Role of Monocyte Chemoattractant Protein 1/JE in . . . Alveolitis in the Rat”, Journal of Immunology, 1992, vol. 149(6), pp. 2147-2154; XP002105552 cited in the application, see the whole document.
Koch et al., Enhanced Production of Monocyte Chemoattractant Protein-1 in Rheumatoid Arthritis, Journal of Clinical Investigation, 1992, vol. 90(3), pp. 772-779; XP002105553, cited in the application, see the whole document.
Krutosikova et al., “Condensed O-, N-Heterocycles by the Transformation of Azidoacrylates”, Monatshefte für Chemie 123, 1992, pp. 807-815.
Kruto{hacek over (s)}iková et al., “Derivatives of Furo[3,2-b]pyrrole”, Collect. Czech. Chem. Commun., vol. 59, 1994, pp. 473-481.
Kruto{hacek over (s)}iková et al., “Reactions of Methyl 2-Formylfuro[3,2-b]pyrrole-5-carboxylates”, Chem. Papers. vol. 50, 1996, pp. 72-76.
Kruto{hacek over (s)}iková et al., “Substituted Benzylfuro[3,2-b]pyrroles”, Collect. Czech. Chem. Commun., vol. 57, 1992, pp. 1487-1494.
Kruto{hacek over (s)}iková et al., “Substituted Vinyl Azides in Synthesis of Furo[3,2-b:4,5-b]-dipyrroles and Pyrrolo[2′,3′:4,5]Furo[3,2-c]pyridines”, Heterocycles. vol. 37, No. 3, 1994, pp. 1695-1700.
Kruto{hacek over (s)}iková et al., “Substituted Vinyl Azides in the Synthesis of Condensed Nitrogen Heterocycles”, Chem. Papers, vol. 48, 1994, pp. 268-273.
Kruto{hacek over (s)}iková et al., “Synthesis and Reactions of Furo[3,2-b]pyurrole Type Aldehydes”, Czech. Chem. Commun., vol. 58, 1993, pp. 2139-2149.
Murakami et al., “Direct Regioselective Vinylationof Indoles Using Palladium (II) Chloride”, Heterocycles, 1984, vol. 22, No. 7, pp. 1493-1496.
Rosenmund et al., “Decarboxylierungen einiger 1-Alkyl-2-carboxy-3-indolessigsäuren sowie Synthese eines 5-Thiocyanato-2,3-dihydroindols”, Chemical Berichte, 1975, vol. 108, pp. 3538-3542, XP-00909395.
Troschütz et al., “Synthesis of Substituted 4-Amino-4-cyano-1-ox

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Monocyte chemoattractant protein-1 inhibitor compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Monocyte chemoattractant protein-1 inhibitor compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Monocyte chemoattractant protein-1 inhibitor compounds will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3480007

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.